Kevin Tracey

President and CEO, Feinstein Institute for Medical Research

Michael Adcock

VP of Population Health Management and Clinical Operations at Centene Corporation; Founder of Adcock Advisory Group

Charlotte Jones-Burton

Senior Vice President at Chinook Therapeutics

Dr. David Cox

Chief Medical Officer at Headspace; Chief Digital Officer & Co-founder at Closed Loop Medicine

Ghada Abdallah

Clinical Pharmacist, Beaumont Health

Samuel Sternberg

Protein-RNA Biochemist, CRISPR Expert, & Author of "A Crack in Creation;" Assistant Biochemistry & Molecular Biophysics Professor at Columbia University

Robert I. Grossman

NYU School of Medicine & Chief Executive Officer NYU Langone Health

Dr. Billy Goldberg

Emergency Medicine Physician & Author of "Why Do Men Have Nipples? Hundreds of Questions You'd Only Ask a Doctor After Your Third Martini"

Dr. Julie Holland

Psychopharmacologist, Psychiatrist & Author

Lisa Martin

Senior Vice President of Global Procurement & Chief Procurement Officer for GSK

Doug Drysdale

Pharmaceutical Industry Entrepreneur; CEO at Cybin, Inc.

Doug Drysdale - Beyond Innovation TV

Kristen Fortney

Scientist Focused on Aging & Bioinformatics; CEO at BioAge Labs

Kristen Fortney | Milken Global Conference

Alice Pomponio

Managing Director, BrightEdge & Vice President Innovation & Impact Investing at American Cancer Society

Alice Pomponio - American Cancer Society

David Altshuler

Executive Vice President & Chief Scientific Officer at Vertex Pharmaceuticals

Michael Sneed

Former Executive Vice President, Global Corporate Affairs & Chief Communication Officer at Johnson & Johnson; Member of the Board of Directors at Kenvue

Dr. Paul Conti

Psychiatrist, Consultant & Author of "Trauma: The Invisible Epidemic"

Trauma: The Invisible Epidemic: How Trauma Works and How We Can Heal From It

Arun Shastri

Global AI Leader at ZS Associates & Thought Leader

Michael Botticelli

Executive Director of the Grayken Center for Addiction at Boston Medical Center

Binta Beard

Head of US Social Impact at Novartis & President of Novartis US Foundation

Bill Anderson

CEO of Bayer AG

Bill Anderson - World Economic Forum 2024